Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis
Timothy Vollmer, Jeffrey A. Cohen, Enrique Álvarez, Kavita Nair, Aaron Boster, Joshua Katz, Gabriel Pardo, Jinglan Pei, Pranil Raut, Sharmin Merchant, Elizabeth A. MacLean, Ashish Pradhan, Brandon Moss
Topics & Concepts
OcrelizumabMedicineCohortMultiple sclerosisClinical endpointAdverse effectAnesthesiaSurgeryInternal medicineClinical trialLymphomaRituximabPsychiatryMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersPolyomavirus and related diseases